Seungjun Yeo is a co-founder and CEO of Dalton Bioanalytics. Dalton Bioanalytics is a UCLA Spin-out startup digitizing the biochemical composition of blood for the future of human health. At Dalton, he commercialized Omni-MS® platform that profiles proteins, lipids, metabolites, and other small molecules in a single assay, generating a single-shot multi omics assay. He joined UCLA Anderson Venture Accelerator with his first company and IndieBio Accelerator with Dalton Bioanalytics. Seungjun served in the Republic of Korea Army in a task force team. He was named to the 2020 LA Business Journal 20 in Their 20s list. Seungjun received a BS in Business Economics from UCLA and certification for entrepreneurship at UCLA Anderson School of Business.